Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone With or Without Veliparib in Metastatic Castration-Resistant Prostate Cancer
NCT01576172Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2012
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in prostate cancer (PCa), sponsored by National Cancer Institute. Started Mar 2012; status: completed.
02
Drugs
veliparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01576172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576172.